Table 7:
Cumulative serologic response following a single dose of TV003 or TV005 in flavivirus-naïve subjects
| % seroconverted | ||||
|---|---|---|---|---|
| DENV-1 | DENV-2 | DENV-3 | DENV-4 | |
| TV003 (N=581) | 97.0 | 64.0 | 98.0 | 100.0 |
| TV005 (n=591) | 91.5 | 86.4 | 94.9 | 96.6 |
| Geometric Mean Peak Titer (Median)2,3 | ||||
| DENV-1 | DENV-2 | DENV-3 | DENV-4 | |
| TV003 (N=821) | 70.6 (75) | 45.2 (50) | 68.1 (57) | 123.3 (133) |
| TV005 (n=591) | 54.4 (43) | 89.3 (101) | 80.6 (78) | 164.7 (172) |
| Percent of TV005 recipients with indicated multivalent response (cumulative) | ||||
| TETRA | TRI | BI | MONO | |
| TV003 (N=821) | 65.5 | 29.3 (94.8) | 5.2 (100) | 0 (100) |
| TV005 (n=591) | 79.7 | 15.3 (95.0) | 1.7 (96.7) | 3.3 (100) |
From CIR268 and CIR279
Based on PRNT50. Seropositive response is defined as a PRNT50 ≥ 1:10 by Study Day 90.
PRNT50 titer calculated only for those subjects who seroconverted